Cargando…
Proteinase-activated receptor 2 (PAR(2)) in hepatic stellate cells – evidence for a role in hepatocellular carcinoma growth in vivo
BACKGROUND: Previous studies have established that proteinase-activated receptor 2 (PAR(2)) promotes migration and invasion of hepatocellular carcinoma (HCC) cells, suggesting a role in HCC progression. Here, we assessed the impact of PAR(2) in HCC stromal cells on HCC growth using LX-2 hepatic stel...
Autores principales: | Mußbach, Franziska, Ungefroren, Hendrik, Günther, Bernd, Katenkamp, Kathrin, Henklein, Petra, Westermann, Martin, Settmacher, Utz, Lenk, Lennart, Sebens, Susanne, Müller, Jörg P., Böhmer, Frank-Dietmar, Kaufmann, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966804/ https://www.ncbi.nlm.nih.gov/pubmed/27473374 http://dx.doi.org/10.1186/s12943-016-0538-y |
Ejemplares similares
-
Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact
por: Gieseler, Frank, et al.
Publicado: (2013) -
Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer
por: Witte, David, et al.
Publicado: (2016) -
Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling
por: Ungefroren, Hendrik, et al.
Publicado: (2017) -
Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer
por: Ungefroren, Hendrik, et al.
Publicado: (2018) -
Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5
por: Zeeh, Franziska, et al.
Publicado: (2016)